Retour aux projets

25174.1 PFLS-LS

Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

Résumé

Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

Textes supplémentaires

Abstract

Inositec#s proprietary platform of small molecules have been derived from a natural compound and engineered for therapeutic potential. The present project aims to establish pre-clinical proof-of-concept for a novel inhibitor of vascular calcification for chronic kidney disease patients. Vascular calcification is a common consequence of renal insufficiency leading to cardiovascular disease for which there are currently no approved treatments.

Participants

Matthias Ivarsson

Wirtschaftspartner

mattias@inositec.com

Inositec AG Matthias Ivarsson Technoparkstrasse 1 8005 Zürich ZH CH

Jean-Christophe Leroux

Kontaktperson

jean-christophe.leroux@pharma.ethz.ch

ETH Zürich Jean-Christophe Leroux Vladimir-Prelog-Weg 1-5/10 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-12-31
Date de fin
2018-11-30
Coûts totaux approuvés
CHF 244419.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%